Depreciation, Depletion and Amortization of Neurogene Inc. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Neurogene Inc. quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Neurogene Inc. Depreciation, Depletion and Amortization for the quarter ending 30 Sep 2025 was $800,000, unchanged year-over-year.
  • Neurogene Inc. Depreciation, Depletion and Amortization for the twelve months ending 30 Sep 2025 was $3,130,000, a 4.1% decline year-over-year.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2024 was $3,195,000, a 2.1% decline from 2023.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2023 was $3,262,000, a 2.1% increase from 2022.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2022 was $3,196,000, a 145% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

Neurogene Inc. Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,130,000 $800,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $3,130,000 $800,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $3,130,000 $749,000 -$65,000 -8% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $3,195,000 $781,000 -$69,000 -8.1% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $3,264,000 $800,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,264,000 $800,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $3,264,000 $814,000 +$2,000 +0.25% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $3,262,000 $850,000 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $800,000 01 Jul 2023 30 Sep 2023 10-Q 18 Nov 2024 2024 Q3
Q2 2023 $800,000 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $812,000 +$401,000 +98% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $411,000 +$164,000 +66% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $247,000 +$76,000 +44% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $171,000 +$130,000 +317% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q1 2019 $41,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q2 2014 $71,938 +$56,346 +361% 29 Mar 2014 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 $18,238 +$3,453 +23% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q2 2013 $15,592 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014 2014 Q2
Q1 2013 $14,785 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q1

Neurogene Inc. Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,195,000 -$67,000 -2.1% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $3,262,000 +$66,000 +2.1% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $3,196,000 +$1,890,000 +145% 01 Jan 2022 31 Dec 2022 10-K 18 Mar 2024 2023 FY
2021 $1,306,000 +$521,000 +66% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
2020 $785,000 +$445,000 +131% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $340,000 +$51,000 +18% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $289,000 -$71,000 -20% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $360,000 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020 2019 FY
2014 $135,946 +$76,375 +128% 01 Jan 2014 31 Dec 2014 10-K 16 Mar 2015 2014 FY
2013 $59,571 -$71,213 -54% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015 2014 FY
2012 $130,784 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.